Literature DB >> 25637479

On-label and off-label drug use in the treatment of endometriosis.

Alexander M Quaas1, Elizabeth A Weedin2, Karl R Hansen2.   

Abstract

Endometriosis, characterized by the presence of endometrial glands and stroma in extrauterine locations, is a significant cause of pelvic pain and infertility, as well as a major health care burden. Although Food and Drug Administration (FDA)-approved treatments are available, the use of "off-label" medications for endometriosis is widespread. In this review, we provide an overview of the current FDA-approved treatments, followed by a detailed review of the major "off-label" treatments being used in the United States and worldwide, including efficacy, side effects, drug interactions, contraindications, and anomaly risks.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometriosis; off-label treatment

Mesh:

Substances:

Year:  2015        PMID: 25637479     DOI: 10.1016/j.fertnstert.2015.01.006

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations.

Authors:  Anteneh Belayneh; Ebisa Tadese; Fantahun Molla
Journal:  Int J Gen Med       Date:  2020-11-09

Review 2.  Hormonal treatments for endometriosis: The endocrine background.

Authors:  Silvia Vannuccini; Sara Clemenza; Margherita Rossi; Felice Petraglia
Journal:  Rev Endocr Metab Disord       Date:  2021-08-17       Impact factor: 9.306

Review 3.  Clinical evaluation and management of endometriosis: guideline for Korean patients from Korean Society of Endometriosis.

Authors:  Hyejin Hwang; Youn-Jee Chung; Sa Ra Lee; Hyun-Tae Park; Jae-Yen Song; Hoon Kim; Dong-Yun Lee; Eun-Ju Lee; Mee-Ran Kim; Sung-Tack Oh
Journal:  Obstet Gynecol Sci       Date:  2018-09-07

Review 4.  Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology.

Authors:  Helena Malvezzi; Eliana Blini Marengo; Sérgio Podgaec; Carla de Azevedo Piccinato
Journal:  J Transl Med       Date:  2020-08-12       Impact factor: 5.531

Review 5.  Adjuvants in IVF-evidence for what works and what does not work.

Authors:  Luciano Nardo; Spyridon Chouliaras
Journal:  Ups J Med Sci       Date:  2020-05-07       Impact factor: 2.384

Review 6.  A Clinician's Guide to the Treatment of Endometriosis with Elagolix.

Authors:  Nicholas Leyland; Stephanie J Estes; Bruce A Lessey; Arnold P Advincula; Hugh S Taylor
Journal:  J Womens Health (Larchmt)       Date:  2020-09-22       Impact factor: 2.681

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.